A retrospective, multicenter study of therapeutic efficacy of molecular targeted therapies following nivolumab in metastatic renal cell carcinoma patients
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Carcinoma; Renal cell carcinoma
- Focus Therapeutic Use
- 03 Nov 2021 New trial record